Risk factors for the development of diabetic nephropathy
Introduction. Results of epidemiological analysis show that one third of patients with diabetes mellitus develop diabetic nephropathy (DN). Strategies used until now to slow down the progression of DN were initiated when the symptoms of DN were already present. Objective. Our objective was to analyz...
Hlavní autoři: | Antić Miodrag, Jotić Aleksandra, Radović Milan, Seferović Jelena P., Lalić Nebojša M., Jovanović Dijana, Ležaić Višnja |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
Serbian Medical Society
2009-01-01
|
Edice: | Srpski Arhiv za Celokupno Lekarstvo |
Témata: | |
On-line přístup: | http://www.doiserbia.nb.rs/img/doi/0370-8179/2009/0370-81790902018A.pdf |
Podobné jednotky
-
Clinical and Histopathological Factors Influencing IgA Nephropathy Outcome
Autor: Andrzej Konieczny, a další
Vydáno: (2021-09-01) -
Diabetic nephropathy in type 2 diabetes: the frequency and risk factors
Autor: Marijana Kovačević, a další
Vydáno: (2019-12-01) -
Immunoglobulin A-nephropathy: modern view of the problem and treatment options
Autor: I. T. Murkamilov, a další
Vydáno: (2021-06-01) -
Secondary Publication: Clinical Grade of IgA Nephropathy
Autor: Takahito Moriyama, a další
Vydáno: (2020-03-01) -
Efficacy and safety of Kunxian in IgA nephropathy
Autor: Yang Yang, a další
Vydáno: (2025-03-01)